A Phase 1 Trial of Autologous Monocytes Stimulated Ex Vivo With Sylatron® (Peginterferon Alfa-2b) and Actimmune® (Interferon Gamma-1b) for Intra-Peritoneal Administration in Recurrent Ovarian Cancer
Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-018-1569-5
Full Text
Open PDFAbstract
Available in full text
Date
July 16, 2018
Authors
Publisher
Springer Science and Business Media LLC